Russell Investments Group, Ltd. Vanda Pharmaceuticals Inc. Transaction History

Russell Investments Group, Ltd.

$66.8 Billion
Q3 2024

A detailed history of Russell Investments Group, Ltd. transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 53,525 shares of VNDA stock, worth $272,977. This represents 0.0% of its overall portfolio holdings.

Number of Shares

53,525

Previous 62,827 14.81%

Holding current value

$272,977

Previous $354,000 29.1%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$4.61 - $6.34 $42,882 - $58,974	-9,302 Reduced 14.81%	53,525 $251,000
Q2 2024 Aug 08, 2024	BUY	$3.91 - $6.5 $1,313 - $2,184	336 Added 0.54%	62,827 $354,000
Q1 2024 May 08, 2024	SELL	$3.47 - $4.61 $31,195 - $41,443	-8,990 Reduced 12.58%	62,491 $256,000
Q4 2023 Feb 05, 2024	SELL	$3.38 - $4.58 $88,363 - $119,734	-26,143 Reduced 26.78%	71,481 $301,000
Q3 2023 Nov 13, 2023	BUY	$4.28 - $6.57 $238,443 - $366,021	55,711 Added 132.92%	97,624 $421,000
Q2 2023 Aug 10, 2023	BUY	$5.9 - $6.95 $3,699 - $4,357	627 Added 1.52%	41,913 $276,000
Q1 2023 May 09, 2023	SELL	$6.18 - $7.99 $505,116 - $653,054	-81,734 Reduced 66.44%	41,286 $280,000
Q4 2022 Feb 08, 2023	BUY	$6.87 - $10.96 $196,062 - $312,787	28,539 Added 30.21%	123,020 $909,000
Q3 2022 Nov 04, 2022	BUY	$9.44 - $11.76 $507,947 - $632,782	53,808 Added 132.29%	94,481 $932,000
Q2 2022 Jul 29, 2022	SELL	$9.31 - $11.84 $90,679 - $115,321	-9,740 Reduced 19.32%	40,673 $442,000
Q1 2022 May 05, 2022	SELL	$10.84 - $16.55 $360,137 - $549,840	-33,223 Reduced 39.72%	50,413 $568,000
Q4 2021 Jan 21, 2022	SELL	$15.69 - $21.14 $400,283 - $539,323	-25,512 Reduced 23.37%	83,636 $1.31 Million
Q3 2021 Nov 08, 2021	SELL	$15.35 - $21.27 $271,879 - $376,734	-17,712 Reduced 13.96%	109,148 $1.87 Million
Q2 2021 Aug 04, 2021	SELL	$15.71 - $21.51 $1.45 Million - $1.98 Million	-92,004 Reduced 42.04%	126,860 $2.73 Million
Q1 2021 May 10, 2021	SELL	$13.42 - $20.28 $973,419 - $1.47 Million	-72,535 Reduced 24.89%	218,864 $3.28 Million
Q4 2020 Feb 08, 2021	SELL	$9.77 - $13.81 $646,090 - $913,255	-66,130 Reduced 18.5%	291,399 $3.83 Million
Q3 2020 Nov 09, 2020	BUY	$9.32 - $12.02 $1.94 Million - $2.51 Million	208,421 Added 139.78%	357,529 $3.43 Million
Q2 2020 Aug 05, 2020	SELL	$9.66 - $12.02 $1.35 Million - $1.68 Million	-140,018 Reduced 48.43%	149,108 $1.68 Million
Q1 2020 May 06, 2020	SELL	$7.5 - $16.8 $105,472 - $236,258	-14,063 Reduced 4.64%	289,126 $2.91 Million
Q4 2019 Jan 29, 2020	BUY	$12.38 - $17.47 $657,452 - $927,761	53,106 Added 21.24%	303,189 $4.97 Million
Q3 2019 Nov 01, 2019	BUY	$12.27 - $15.79 $957,513 - $1.23 Million	78,037 Added 45.36%	250,083 $3.36 Million
Q2 2019 Aug 09, 2019	BUY	$13.37 - $18.85 $383,384 - $540,523	28,675 Added 20.0%	172,046 $2.46 Million
Q1 2019 May 13, 2019	BUY	$17.59 - $31.05 $1.17 Million - $2.07 Million	66,537 Added 86.6%	143,371 $2.67 Million
Q4 2018 Feb 11, 2019	BUY	$18.97 - $31.47 $680,795 - $1.13 Million	35,888 Added 87.65%	76,834 $1.99 Million
Q3 2018 Oct 26, 2018	SELL	$18.25 - $23.0 $36,372 - $45,839	-1,993 Reduced 4.64%	40,946 $940,000
Q2 2018 Aug 08, 2018	SELL	$13.95 - $19.15 $15,707 - $21,562	-1,126 Reduced 2.56%	42,939 $818,000
Q1 2018 May 11, 2018	BUY	$14.05 - $20.2 $538,283 - $773,902	38,312 Added 665.95%	44,065 $742,000
Q4 2017 Feb 06, 2018	SELL	$12.85 - $18.1 $114,018 - $160,601	-8,873 Reduced 60.67%	5,753 $88,000
Q3 2017 Nov 07, 2017	BUY	$15.4 - $18.85 $225,240 - $275,700	14,626	14,626 $262,000

Others Institutions Holding VNDA

# of Institutions

161

Shares Held

45.5M

Call Options Held

150K

Put Options Held

33.6K

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $288M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account

Russell Investments Group, Ltd. Vanda Pharmaceuticals Inc. Transaction History